lobbying_activities: 1240309
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1240309 | fd3354ee-a3b9-4c95-92e9-cf13441c89db | Q1 | GEPHARDT GROUP GOVERNMENT AFFAIRS | 315717 | HEALIANCE PHARMACEUTICALS | 2012 | first_quarter | PHA | innovative diabetes treatment | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T17:42:58.710000-04:00 |